Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Additionally, we analyze its potential as multidisease biomarker, crosstalk mediator, and therapeutic target, providing new strategies and perspectives for drug research and the prevention and treatment of various diseases
Dosey, H
The development of GLP-/GIP dual agonists provides a more complete scheme for the treatment of metabolic diseases, but the safety of more dual agonists or multiple agonists in clinical trials is also worthy of attention
You may only eat half a sandwich whereas normally you would have eaten 2
US$ 20.41
US$ 28.30
US$ 29.69
US$ 21.05
US$ 23.77
